An offshore trial has found a link between kidney malfunction and Alzheimer's, while a local biotech legend takes a different ...

The Elliot family feels like a weight has been lifted off their shoulders after receiving a letter that their son’s life-saving infusion will be covered by insurance.

Drug approvals this year have reflected the trend in clinical development of biologics shifting from intravenous to ...

Eisai has submitted a new drug application to Japan’s PMDA seeking approval for Leqembi’s SC formulation, SC-AI, for early ...

The family’s insurance company, Blue Cross Blue Shield of Oklahoma, denied coverage of Adam’s Intravenous Immunoglobulin, or ...

CliniExperts Research Services Pvt. Ltd., New Delhi, India proudly announces the successful completion of Phase IV study on Akynzeo I.V for Glenmark Pharmaceuticals ltd. As a CRO, CliniExperts ...

Unfortunately, my experience is all too common. If you find yourself in a situation like I did, here's what you should do.

Bank of America Leveraged Finance Conference December 2, 2025 10:50 AM ESTCompany ParticipantsNicole Maggio - Senior ...

Anaphylactic reactions to iodinated contrast media (ICM) might be rare but cases that do occur often have a dangerous pattern of non-resolving or recurring symptoms despite treatment, a large analysis ...

Capricor Therapeutics, Inc. soars 450% on positive HOPE-3 DMD results. Discover market impact, growth potential, and risks.

Orsini, a leader in rare disease pharmacy solutions, announced today that it is a specialty pharmacy partner for ITVISMA® (onasemnogene abeparvovec-brve), an FDA-approved intrathecal gene therapy for ...

There was also a shared emphasis on expanding and integrating clinical trials through broadening trial eligibility criteria ...